CPHI vs T · rev $4.5M vs P/E 7.4, rev $125.65B
China Pharma Holdings Inc (CPHI) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported T revenue for 2025-12-31 was $125.65B. Net income was $21.95B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. T currently screens at market cap $155.92B and trailing P/E 7.4.
CPHI currently screens at market cap $29.0M. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the CPHI and T stock pages for the full models.
Not investment advice.